Choi Yunsu, Ahn Kyoung Hwan, Kim Soo Min, Choi Bo Youl, Choi Jungsoon, Kim Jung Ho, Kim Shin-Woo, Kim Youn Jeong, Jun Yoon Hee, Park Bo Young
Institute for Health and Society, Hanyang University, Seoul, Korea.
Department of Preventive Medicine, College of Medicine, Hanyang University, Seoul, Korea.
Infect Chemother. 2024 Dec;56(4):510-521. doi: 10.3947/ic.2024.0085.
The Korean government is implementing policy to reduce medical costs and improve treatment related for human immunodeficiency virus (HIV) patients. The level of cost reduction and the benefits provided vary depending on how individuals with HIV utilize the system. This study aims to determine exact HIV prevalence by analyzing healthcare utilization patterns and examining differences in healthcare usage based on how individuals pay for their medical expenses.
We analyzed National Health Insurance Service (NHIS) claims data from 2002 to 2021. From a total of 106,675 individuals with at least one HIV-related claim, 22,779 participants were selected for this study.
Data from Korea Disease Control and Prevention Agency annual reports indicated that 93% of HIV patients were male, while NHIS data showed 84%. In the analysis of those exempted from registration, it was found that the registration rate for female patients is notably low, with adults between the ages of 20 and 40 making up 80% of the total. The registration rate in Gangwon State was lower than Seoul. The treatment experience rate was much higher in the registered group (93.0%) than the unregistered group (4.9%). Also, there was a big difference in treatment continuity rates: 76.2% for registered individuals and 2.8% for non-registered individuals.
The exempt calculation system for health insurance improves HIV care. However, those diagnosed anonymously or with reduced medical costs may be less likely to continue HIV treatment, so a new policy is needed to ensure anonymity and treatment continuity.
韩国政府正在实施相关政策,以降低医疗成本并改善人类免疫缺陷病毒(HIV)患者的治疗相关情况。成本降低的程度和所提供的福利因HIV感染者使用该系统的方式而异。本研究旨在通过分析医疗保健利用模式并根据个人支付医疗费用的方式检查医疗保健使用差异,来确定确切的HIV流行率。
我们分析了2002年至2021年的国民健康保险服务(NHIS)理赔数据。从总共106,675名至少有一项与HIV相关理赔的个体中,选择了22,779名参与者进行本研究。
韩国疾病控制与预防机构年度报告的数据表明,93%的HIV患者为男性,而NHIS数据显示为84%。在对豁免登记者的分析中,发现女性患者的登记率明显较低,20至40岁的成年人占总数的80%。江原道的登记率低于首尔。登记组的治疗经历率(93.0%)远高于未登记组(4.9%)。此外,治疗持续率也存在很大差异:登记个体为76.2%,未登记个体为2.8%。
医疗保险豁免计算系统改善了HIV护理。然而,那些匿名诊断或医疗成本降低的人可能不太可能继续接受HIV治疗,因此需要一项新政策来确保匿名性和治疗连续性。